Cannabis is a cannabinoid drug. The number of different cannabinoids in the cannabis sativa plant is still being researched, but two of the most well-known are THC (tetrahydrocannabinol) and CBD (cannabidiol). These compounds interact with the body's endocannabinoid system, which plays a role in regulating various functions such as mood, appetite, and pain sensation.
Cannabidiol (CBD) is an active ingredient in cannabis that is derived from the hemp plant, but it does not cause a high and is not addictive. It has gained popularity for its potential therapeutic benefits, including pain relief, anxiety reduction, and anti-inflammatory properties. CBD products come in various forms such as oils, edibles, and topicals.
Diagnosis of Cannabis Use Disorder involves a pattern of problematic cannabis use that leads to clinically significant impairment or distress. The new cannabis use disorder classification (which separates problematic use from cannabis dependence or addiction) highlights the need for proper assessment and treatment options for individuals struggling with cannabis misuse.
Earlier this year, the 2018 Farm Bill legalized the production and sale of hemp-derived CBD products in the United States. To meet the federal definition of hemp under the bill, a cannabis product must contain less than 0.3 percent delta-9 THC, the psychoactive compound responsible for the "high" associated with marijuana.
The Effects of Cannabis are varied and can include pain relief, improved sleep, muscle relaxation, and potential benefits for neurological conditions such as epilepsy and multiple sclerosis. Research on the therapeutic uses of cannabis is ongoing, with promising results in various medical fields.
Marijuana is considered a schedule I drug, which means it is classified as highly dangerous, addictive, and lacking medical value according to federal law. However, there is a growing body of evidence supporting the medical benefits of cannabis, leading to calls for its reclassification and increased access for patients in need.
Popular on Rolling Stone. For cannabis companies, this revelation is not just an interesting statistic; it is a roadmap to success. With a rapidly expanding market and changing regulations, businesses in the cannabis industry must stay informed and adapt to meet consumer demands while complying with legal requirements.
Editor's note: This is a developing story. Updated, 11 a.m., May 24, to include additional information re: other hemp changes in the Farm Bill. Stay tuned for further updates on the evolving landscape of cannabis legislation and research.
